Productively Combining Proteasome Inhibition With the Immunotherapy of Cancer

Journal of Molecular Medicine - Germany
doi 10.1007/s00109-008-0384-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Combining Epigenetic and Immunotherapy to Combat Cancer

Cancer Research
Cancer ResearchOncology
2016English

Combining Microenvironment Normalization Strategies to Improve Cancer Immunotherapy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2020English

Combining Immunotherapy With Radiation Therapy in Thoracic Oncology

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Clinical Opportunities in Combining Immunotherapy With Radiation Therapy

Frontiers in Oncology
Cancer ResearchOncology
2012English

Melanoma Immunotherapy Using Mature DCs Expressing the Constitutive Proteasome

Journal of Clinical Investigation
Medicine
2013English

Terazosin Suppress Human Prostatic Cancer PC3 Cell Viability via Proteasome Inhibition

Biology and Medicine
BiochemistryGeneticsMolecular Biology
2014English

Combined Autophagy and Proteasome Inhibition

Autophagy
Cell BiologyMolecular Biology
2014English

Strong Emerging Rationale for Combining Oncogene-Targeted Agents With Immunotherapy

OncoImmunology
OncologyAllergyImmunology
2013English

Moving Cancer Immunotherapy Forward Through the Journal for ImmunoTherapy of Cancer (JITC)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy